Pharmaceutical products

Tender description

Medicines included in this framework agreement are generic medicines listed in the British National Formulary (BNF) used to treat cardiovascular and respiratory conditions. The Goods have been split into thirteen (13) categories, each of which is identified as a ‘Lot’. Full details of each Lot is contained in section II.2 of this notice. Supply of Epoprostenol 500mcg and 1.5mg powder and solvent (pH10.5) for solution for infusion vials to NHS Scotland. The Authority intended to award a multi-supplier unranked framework agreement for the Lot to an envisaged maximum of 6 Suppliers. Supply of Epoprostenol 500mcg and 1.5mg powder and solvent (pH12) for solution for infusion vials to NHS Scotland. The Authority intended to award a multi-supplier unranked framework agreement for the Lot to an envisaged maximum of 6 Suppliers. Supply of Epinephrine (Adrenaline) Auto Injector Devices to NHS Scotland in a range of presentations. The Authority intended to award each product line as a multi-supplier unranked framework agreement on a line by line basis to an envisaged maximum of 6 Suppliers. Supply of Epinephrine (Adrenaline) Injections to NHS Scotland in a range of presentations. The Authority intended to award each product line as a multi-supplier unranked framework agreement on a line by line basis to an envisaged maximum of 6 Suppliers. Supply of Nifedipine Modified Release Capsules and Tablets to NHS Scotland in a range of presentations. The Authority intended to award each product line as a multi-supplier unranked framework agreement on a line by line basis to an envisaged maximum of 6 Suppliers. Supply of Fondaparinux Pre-filled Syringes to NHS Scotland in a range of presentations. The Authority intended to award each product line as a multi-supplier unranked framework agreement on a line by line basis to an envisaged maximum of 6 Suppliers. Supply of Urokinase Injections to NHS Scotland in a range of presentations. The Authority intended to award each product line as a multi-supplier unranked framework agreement on a line by line basis to an envisaged maximum of 6 Suppliers. Supply of Isosorbide Mononitrate Modified Release Capsules and Tablets to NHS Scotland in a range of presentations. The Authority intended to award each product line as a multi-supplier unranked framework agreement on a line by line basis to an envisaged maximum of 6 Suppliers. Supply of Diltiazem Hydrochloride Modified Release Capsules and Tablets to NHS Scotland in a range of presentations. The Authority intended to award each product line as a multi-supplier unranked framework agreement on a line by line basis to an envisaged maximum of 6 Suppliers. Supply of Verapamil Hydrochloride Modified Release Capsules and Tablets to NHS Scotland in a range of presentations. The Authority intended to award each product line as a multi-supplier unranked framework agreement on a line by line basis to an envisaged maximum of 6 Suppliers. Supply of Theophylline Modified Release Capsules and Tablets to NHS Scotland in a range of presentations. The Authority intended to award each product line as a multi-supplier unranked framework agreement on a line by line basis to an envisaged maximum of 6 Suppliers. Supply of Branded and Branded Generic Inhalers to NHS Scotland in a range of presentations. The Authority intended to award each product line as a multi-supplier unranked framework agreement on a line by line basis to an envisaged maximum of 6 Suppliers. Supply of all other Cardiovascular & Respiratory Medicines to NHS Scotland in a range of presentations. The Authority intended to award each line within this lot to a single supplier.